Could National Vet Care be an IPO worth backing?

National Vet Care is hoping to run a growth by acquisition model similar to that which has made Greencross Limited (ASX:GXL), and G8 Education Ltd (ASX:GEM) so successful in recent years.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Regular readers may have seen my article on Monday about National Vet Care, the upcoming Initial Public Offering (IPO) and would-be Greencross Limited (ASX: GXL) hopeful.

In case you missed it here's a quick recap:

  • National Vet Care owns one clinic and with the IPO process hopes to attract enough investors to complete the purchase of a further 34, giving the company approximately $50 million in revenue
  • This will make National Vet Care the second largest veterinary provider in the country with 35 clinics, behind Greencross with 125
  • NVC will acquire 15 more clinics in the first year followed by 10 per year after that, ideally on a multiple of between 3-5x normalised Earnings Before Interest and Tax (EBIT)
  • National Vet Care will stick solely to providing clinical services, avoiding the retail sector that has troubled Greencross shareholders lately
  • NVC's board includes former GXL General Manager Tomas Steenackers, former Chief Financial Officer (CFO) Wesley Coote, and the chairwoman is Susan Forrester who also sits on the board of G8 Education Ltd (ASX: GEM)
  • The offer booklet is expected out in early July, with the ASX debut a few weeks later

There are a number of risks including single-clinic NVC's relative lack of experience with acquisitions and lack of a unified brand; investors will also need detailed information on NVC's finances, margins and so on before buying into the company. Given that 50% of IPOs trade below their offer price in the first year of trading, price is also an important consideration.

Based on a slowing IPO market and the low prices of companies with a similar roll-up growth model, I think there's a fair chance investors will find NVC launching at an appealing price, unlike the exorbitant asking price of some recent launches.

Here's a quick comparison of similar company Price to Earnings (P/E) ratios:

G8 Education Limited – 19.5, forward P/E (for 2015 full-year earnings) 16

Affinity Education Group Ltd (ASX: AFJ) – not yet profitable, Price to Underlying Earnings ratio is ~12

Greencross Limited – P/E of 18, forward P/E of 17

1300 Smiles Limited (ASX: ONT) – P/E of 31, forward P/E of 23

Based on this quick comparison I wouldn't be surprised to see National Vet Care launch with a P/E of 18 or 19. That depends on many factors however, including the cost of the initial 34 centres.

It's not necessarily a good deal either as there are many risks, but a planned acquisition of 15 centres in the first year out could see revenue jump by 40%, and 10 centres per year after that could see growth of 20%, 16%, 14% and 12% for each of the first five years.

The potential appears to be there – now it's all about calculating risk. National Vet Care looks like a small cap well worth further investigation.

Motley Fool contributor Sean O'Neill owns shares of G8 Education Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »